ICYMI: AstraZeneca Profit, Revenue Lifted by Cancer Drugs
July 30, 2025
14 min
Full
4,841 of 5,353
July 30, 2025
ICYMI: AstraZeneca Profit, Revenue Lifted by Cancer Drugs
0:00 / 14:39
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
Bloomberg Originals Episodes Around July 30, 2025
Episode 4,841 of 5,353 — walk the feed in the order it was published.
14:39This episodeICYMI: AstraZeneca Profit, Revenue Lifted by Cancer Drugs
Summary
<p>AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer medicines and growth in the US.<br /><br />Revenue climbed 12% to $14.5 billion, the UK drugmaker said Tuesday, beating estimates. Earnings per share excluding some items rose 10% to $2.17, as expected. Under Chief Executive Officer Pascal Soriot’s watch, Astra has turned into an oncology powerhouse and is increasingly focused on the US. Pascal discusses his company's strong quarterly performance and the state of the pharmaceutical industry with Tim Stenovec and Carol Massar on Bloomberg Businessweek Daily.</p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>
Episode details and artwork are published by the show’s own feed. Sentinel plays short cited excerpts and links every episode back to its publisher.